Threat Reduction Advisory Committee; Notice of Federal Advisory Committee Meeting, 50088 [2012-20415]

Download as PDF 50088 Federal Register / Vol. 77, No. 161 / Monday, August 20, 2012 / Notices Reserve Forces Policy Board until its next meeting. The Designated Federal Officer will review all timely submitted written statements and provide copies to all the committee members before the meeting that is the subject of this notice. Dated: August 15, 2012. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2012–20416 Filed 8–17–12; 8:45 am] BILLING CODE 5001–06–P DEPARTMENT OF DEFENSE Office of the Secretary Threat Reduction Advisory Committee; Notice of Federal Advisory Committee Meeting Department of Defense, Office of the Under Secretary of Defense (Acquisition, Technology and Logistics). ACTION: Federal advisory committee meeting notice. AGENCY: Under the provisions of the Federal Advisory Committee Act of 1972 (5 U.S.C., Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended) the Department of Defense announces the following Federal advisory committee meeting of the Threat Reduction Advisory Committee (hereafter referred to as ‘‘the Committee’’). SUMMARY: Thursday, September 6, 2012, from 8:30 a.m. to 5 p.m. and Friday, September 7, 2012, from 8:30 a.m. to 3 p.m. ADDRESSES: Conference Room 3A912A, The Pentagon. FOR FURTHER INFORMATION CONTACT: Mr. William Hostyn, GS–15, DoD, Defense Threat Reduction Agency/J2/5/8R, 8725 John J. Kingman Road, MS 6201, Fort Belvoir, VA 22060–6201. Email: william.hostyn@dtra.mil. Phone: (703) 767–4453. Fax: (703) 767–4206. SUPPLEMENTARY INFORMATION: Purpose of Meeting: To obtain, review and evaluate classified information related to the Committee’s mission to advise on technology security, combating weapons of mass destruction (C–WMD), counter terrorism and counter proliferation. Agenda: Beginning at 8:30 a.m. on September 6, and through the end of the meeting on September 7, the committee will receive classified Combating Weapons of Mass Destruction (C–WMD) briefings from the Department of Defense and the Intelligence Community. The committee will also mstockstill on DSK4VPTVN1PROD with NOTICES DATES: VerDate Mar<15>2010 16:25 Aug 17, 2012 Jkt 226001 hold classified discussions on Middle East WMD concerns, the Cost Assessment and Program Evaluation Study, and Advance Smart Nuclear Awareness, Control and Accountability. Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.155, the Department of Defense has determined that the meeting shall be closed to the public. The Under Secretary of Defense for Acquisition, Technology and Logistics, in consultation with the DoD FACA Attorney, has determined in writing that the public interest requires all sessions of this meeting be closed to the public because the discussions will be concerned with classified information and matters covered by 5 U.S.C. 552b(c)(1) and are inextricably intertwined with the unclassified material which cannot reasonably be segregated into separate discussions without disclosing secret material. Committee’s Designated Federal Officer or Point of Contact: Mr. William Hostyn, GS–15, DoD, Defense Threat Reduction Agency/J/2/5/8R, 8725 John J. Kingman Road, MS 6201, Fort Belvoir, VA 22060–6201. Email: william.hostyn@dtra.mil. Phone: (703) 767–4453. Fax: (703) 767–4206. Written Statements: Pursuant to 41 CFR 102–3.105(j) and 102–3.140 and section 10(a)(3) of the Federal Advisory Committee Act of 1972, the public or interested organizations may submit written statements to the membership of the Committee at any time or in response to the stated agenda of a planned meeting. Written statements should be submitted to the Committee’s Designated Federal Officer. The Designated Federal Officer’s contact information is listed in FOR FURTHER INFORMATION CONTACT or it can be obtained from the GSA’s FACA Database—https://www.fido.gov/ facadatabase/public.asp. Written statements that do not pertain to a scheduled meeting of the Committee may be submitted at any time. However, if individual comments pertain to a specific topic being discussed at a planned meeting then these statements must be submitted no later than five business days prior to the meeting in question. The Designated Federal Officer will review all submitted written statements and provide copies to all committee members. Dated: August 15, 2012. Aaron Siegel, Alternate OSD Federal Register Liaison Officer, Department of Defense. [FR Doc. 2012–20415 Filed 8–17–12; 8:45 am] BILLING CODE 5001–06–P PO 00000 Frm 00011 Fmt 4703 Sfmt 4703 DEPARTMENT OF DEFENSE Office of the Secretary Meeting of the Uniform Formulary Beneficiary Advisory Panel Assistant Secretary of Defense (Health Affairs), DoD. ACTION: Notice of meeting. AGENCY: Under the provisions of the Federal Advisory Committee Act of 1972 (Title 5, United States Code (U.S.C.), Appendix, as amended) and the Government in the Sunshine Act of 1976 (5 U.S.C. 552b, as amended) the Department of Defense (DoD) announces the following Federal Advisory Committee Meeting of the Uniform Formulary Beneficiary Advisory Panel (hereafter referred to as the Panel). DATES: September 27, 2012, from 9 a.m. to 1 p.m. ADDRESSES: Naval Heritage Center Theater, 701 Pennsylvania Avenue, NW., Washington, DC 20004. FOR FURTHER INFORMATION CONTACT: CDR Joseph Lawrence, DFO, Uniform Formulary Beneficiary Advisory Panel, 4130 Stanley Road, Suite 208, Building 1000 San Antonio, TX 78234–6012, Telephone: (210) 295–1271, Fax: (210) 295–2789, Email Address: Baprequests@tma.osd.mil. SUMMARY: SUPPLEMENTARY INFORMATION: Purpose of Meeting: The Panel will review and comment on recommendations made to the Director of TRICARE Management Activity, by the Pharmacy and Therapeutics Committee, regarding the Uniform Formulary. Meeting Agenda: 1. Sign-In. 2. Welcome and Opening Remarks. 3. Public Citizen Comments. 4. Scheduled Therapeutic Class Reviews (Comments will follow each agenda item). a. Androgens-Anabolic Steroids. b. Anticoagulants. c. Designated Newly Approved Drugs in Already-Reviewed Classes. d. Pertinent Utilization Management Issues. 5. Panel Discussions and Vote. Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 41 CFR 102–3.140 through 102–3.165, and the availability of space, this meeting is open to the public. Seating is limited and will be provided only to the first 220 people signing-in. All persons must sign-in legibly. Administrative Work Meeting: Prior to the public meeting, the Panel will conduct an Administrative Work E:\FR\FM\20AUN1.SGM 20AUN1

Agencies

[Federal Register Volume 77, Number 161 (Monday, August 20, 2012)]
[Notices]
[Page 50088]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-20415]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Office of the Secretary


Threat Reduction Advisory Committee; Notice of Federal Advisory 
Committee Meeting

AGENCY: Department of Defense, Office of the Under Secretary of Defense 
(Acquisition, Technology and Logistics).

ACTION: Federal advisory committee meeting notice.

-----------------------------------------------------------------------

SUMMARY: Under the provisions of the Federal Advisory Committee Act of 
1972 (5 U.S.C., Appendix, as amended) and the Government in the 
Sunshine Act of 1976 (5 U.S.C. 552b, as amended) the Department of 
Defense announces the following Federal advisory committee meeting of 
the Threat Reduction Advisory Committee (hereafter referred to as ``the 
Committee'').

DATES: Thursday, September 6, 2012, from 8:30 a.m. to 5 p.m. and 
Friday, September 7, 2012, from 8:30 a.m. to 3 p.m.

ADDRESSES: Conference Room 3A912A, The Pentagon.

FOR FURTHER INFORMATION CONTACT: Mr. William Hostyn, GS-15, DoD, 
Defense Threat Reduction Agency/J2/5/8R, 8725 John J. Kingman Road, MS 
6201, Fort Belvoir, VA 22060-6201. Email: william.hostyn@dtra.mil. 
Phone: (703) 767-4453. Fax: (703) 767-4206.

SUPPLEMENTARY INFORMATION:
    Purpose of Meeting: To obtain, review and evaluate classified 
information related to the Committee's mission to advise on technology 
security, combating weapons of mass destruction (C-WMD), counter 
terrorism and counter proliferation.
    Agenda: Beginning at 8:30 a.m. on September 6, and through the end 
of the meeting on September 7, the committee will receive classified 
Combating Weapons of Mass Destruction (C-WMD) briefings from the 
Department of Defense and the Intelligence Community. The committee 
will also hold classified discussions on Middle East WMD concerns, the 
Cost Assessment and Program Evaluation Study, and Advance Smart Nuclear 
Awareness, Control and Accountability.
    Meeting Accessibility: Pursuant to 5 U.S.C. 552b, as amended, and 
41 CFR 102-3.155, the Department of Defense has determined that the 
meeting shall be closed to the public. The Under Secretary of Defense 
for Acquisition, Technology and Logistics, in consultation with the DoD 
FACA Attorney, has determined in writing that the public interest 
requires all sessions of this meeting be closed to the public because 
the discussions will be concerned with classified information and 
matters covered by 5 U.S.C. 552b(c)(1) and are inextricably intertwined 
with the unclassified material which cannot reasonably be segregated 
into separate discussions without disclosing secret material.
    Committee's Designated Federal Officer or Point of Contact: Mr. 
William Hostyn, GS-15, DoD, Defense Threat Reduction Agency/J/2/5/8R, 
8725 John J. Kingman Road, MS 6201, Fort Belvoir, VA 22060-6201. Email: 
william.hostyn@dtra.mil. Phone: (703) 767-4453. Fax: (703) 767-4206.
    Written Statements: Pursuant to 41 CFR 102-3.105(j) and 102-3.140 
and section 10(a)(3) of the Federal Advisory Committee Act of 1972, the 
public or interested organizations may submit written statements to the 
membership of the Committee at any time or in response to the stated 
agenda of a planned meeting. Written statements should be submitted to 
the Committee's Designated Federal Officer. The Designated Federal 
Officer's contact information is listed in FOR FURTHER INFORMATION 
CONTACT or it can be obtained from the GSA's FACA Database--https://www.fido.gov/facadatabase/public.asp.
    Written statements that do not pertain to a scheduled meeting of 
the Committee may be submitted at any time. However, if individual 
comments pertain to a specific topic being discussed at a planned 
meeting then these statements must be submitted no later than five 
business days prior to the meeting in question. The Designated Federal 
Officer will review all submitted written statements and provide copies 
to all committee members.

    Dated: August 15, 2012.
Aaron Siegel,
Alternate OSD Federal Register Liaison Officer, Department of Defense.
[FR Doc. 2012-20415 Filed 8-17-12; 8:45 am]
BILLING CODE 5001-06-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.